NCT02499081View on ClinicalTrials.gov

UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 17, 2018

Study Completion Date

May 17, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

Ixazomib

Trial Locations (1)

72205

University of Arkansas for Medical Science, Little Rock

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

University of Arkansas

OTHER